Susan M. Domchek, M.D.

Dr. Domchek is the Basser Professor in Oncology at the University of Pennsylvania, executive director of the Basser Center for BRCA at the Abramson Cancer Center, and director of the Mariann and Robert MacDonald Cancer Risk Evaluation Program. A medical oncologist, her research focuses on improving the genetic evaluation and medical management of individuals with inherited cancer risk, with particular emphasis on cancer interception and immune-based strategies.
In seminal work, Dr. Domchek demonstrated that risk-reducing salpingo-oophorectomy is associated with improved survival among BRCA1 and BRCA2 mutation carriers. She has been critical to the development of PARP inhibitors in BRCA-associated cancers and in advancing the clinical application of germline genetic testing. An elected member of the National Academy of Medicine and several leading medical societies, she has authored or co-authored more than 500 scientific publications.

